Bloomage BioTechnology Corporation Limited (SHA: 688363)
China
· Delayed Price · Currency is CNY 55.28
+0.34 (0.62%)
Dec 20, 2024, 3:00 PM CST
Bloomage BioTechnology Corporation Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 440.18 | 592.56 | 970.92 | 782.33 | 645.84 | 585.61 | Upgrade
|
| Depreciation & Amortization | 260.74 | 260.74 | 213.61 | 154.33 | 70.19 | 60.4 | Upgrade
|
| Other Amortization | 31.65 | 31.65 | 15.04 | 6.96 | 4.84 | 2.53 | Upgrade
|
| Loss (Gain) From Sale of Assets | 3.42 | 3.42 | 0.49 | -0.04 | -0.05 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.87 | 1.87 | 0.28 | 33.73 | 16.59 | 3.87 | Upgrade
|
| Loss (Gain) From Sale of Investments | 17.41 | 17.41 | -11.77 | -28.04 | -37.52 | -0.45 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.6 | 7.6 | 15.36 | 5.78 | - | - | Upgrade
|
| Other Operating Activities | 221.56 | 30.02 | -1.72 | -1.65 | 5.92 | -5.53 | Upgrade
|
| Change in Accounts Receivable | 54.48 | 54.48 | -98.43 | -36.27 | -64.94 | -181.36 | Upgrade
|
| Change in Inventory | 13.88 | 13.88 | -437.82 | -218.53 | -178.51 | -141.7 | Upgrade
|
| Change in Accounts Payable | -321.54 | -321.54 | -72.85 | 613.39 | 268.41 | 53.4 | Upgrade
|
| Change in Other Net Operating Assets | 42.5 | 42.5 | 103.85 | 114.25 | - | - | Upgrade
|
| Operating Cash Flow | 738.82 | 699.65 | 635.19 | 1,276 | 705.12 | 364.89 | Upgrade
|
| Operating Cash Flow Growth | -1.96% | 10.15% | -50.22% | 80.97% | 93.24% | -17.50% | Upgrade
|
| Capital Expenditures | -857.81 | -1,030 | -696.41 | -784.21 | -762.77 | -450.23 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.21 | 0 | 1.24 | 0.01 | 0.06 | - | Upgrade
|
| Cash Acquisitions | - | - | -155.15 | -138.09 | - | - | Upgrade
|
| Divestitures | - | - | 0.12 | - | - | - | Upgrade
|
| Investment in Securities | 246.2 | 403.67 | -11.17 | -100.1 | -606.88 | -800 | Upgrade
|
| Other Investing Activities | 71.01 | 13.78 | 25.15 | 32.53 | 38.29 | 2.78 | Upgrade
|
| Investing Cash Flow | -540.38 | -612.88 | -836.22 | -989.86 | -1,331 | -1,247 | Upgrade
|
| Long-Term Debt Issued | - | - | 137.83 | 174 | 23.84 | - | Upgrade
|
| Total Debt Issued | 100 | - | 137.83 | 174 | 23.84 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -40 | Upgrade
|
| Long-Term Debt Repaid | - | -173.91 | -84.62 | -54.32 | - | - | Upgrade
|
| Total Debt Repaid | -181.73 | -173.91 | -84.62 | -54.32 | - | -40 | Upgrade
|
| Net Debt Issued (Repaid) | -81.73 | -173.91 | 53.21 | 119.68 | 23.84 | -40 | Upgrade
|
| Issuance of Common Stock | 6 | 51.72 | 84.21 | - | - | 2,369 | Upgrade
|
| Repurchase of Common Stock | -105.89 | -105.89 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -184.62 | -305.48 | -242.86 | -201.01 | -177.6 | - | Upgrade
|
| Other Financing Activities | -97.2 | 6 | -64.71 | 9.98 | -6.17 | -104.7 | Upgrade
|
| Financing Cash Flow | -463.44 | -527.57 | -170.16 | -71.36 | -159.94 | 2,224 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.85 | 10.56 | 29.56 | -19.85 | -12.35 | 6.17 | Upgrade
|
| Net Cash Flow | -258.15 | -430.24 | -341.63 | 194.99 | -798.48 | 1,348 | Upgrade
|
| Free Cash Flow | -118.99 | -330.68 | -61.22 | 491.85 | -57.65 | -85.34 | Upgrade
|
| Free Cash Flow Margin | -2.08% | -5.44% | -0.96% | 9.94% | -2.19% | -4.53% | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.69 | -0.13 | 1.02 | -0.12 | -0.20 | Upgrade
|
| Cash Income Tax Paid | 545.72 | 550.54 | 770.79 | 539.9 | 369.28 | 301.61 | Upgrade
|
| Levered Free Cash Flow | -259.64 | -620.61 | -240.37 | 940.17 | -887.91 | -181.32 | Upgrade
|
| Unlevered Free Cash Flow | -255.11 | -613.9 | -231.29 | 947.09 | -887.91 | -180.3 | Upgrade
|
| Change in Net Working Capital | 3.69 | 274.82 | 455.43 | -1,006 | 618.94 | 211.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.